{"transactions":[{"id":349493,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-03T20:57:02.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":3481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":3481,"derivative":{"exercise_price":342.73,"expiration_date":"2033-04-30","underlying":"Common Stock","underlying_shares":3481},"source":{"system":"sec-edgar","filing":"0001209191-23-027034","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123027034/doc4.xml","form_type":"4"}},{"id":354340,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-31T21:42:11.000Z","date":"2023-01-27","kind":"exercise","acquired":false,"shares":1429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":72.14,"expiration_date":"2024-05-31","underlying":"Common Stock","underlying_shares":1429},"source":{"system":"sec-edgar","filing":"0001209191-23-005712","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123005712/doc4.xml","form_type":"4"}},{"id":354339,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-31T21:42:11.000Z","date":"2023-01-27","kind":"sale","acquired":false,"shares":80,"price":323.33,"value":25866.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."}],"balance_after":1875,"source":{"system":"sec-edgar","filing":"0001209191-23-005712","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123005712/doc4.xml","form_type":"4"}},{"id":354338,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-31T21:42:11.000Z","date":"2023-01-27","kind":"sale","acquired":false,"shares":970,"price":322.2,"value":312534.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $322.20 (range $321.75 to $322.74)."}],"balance_after":1955,"source":{"system":"sec-edgar","filing":"0001209191-23-005712","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123005712/doc4.xml","form_type":"4"}},{"id":354337,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-31T21:42:11.000Z","date":"2023-01-27","kind":"sale","acquired":false,"shares":379,"price":321.31,"value":121776.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $321.31 (range $320.62 to $321.59)."}],"balance_after":2925,"source":{"system":"sec-edgar","filing":"0001209191-23-005712","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123005712/doc4.xml","form_type":"4"}},{"id":354336,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-31T21:42:11.000Z","date":"2023-01-27","kind":"exercise","acquired":true,"shares":1429,"price":72.14,"value":103088.06,"ownership":{"direct":true},"balance_after":3304,"source":{"system":"sec-edgar","filing":"0001209191-23-005712","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123005712/doc4.xml","form_type":"4"}},{"id":354487,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-27T21:18:18.000Z","date":"2023-01-26","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Fully vested."}],"balance_after":1429,"derivative":{"exercise_price":72.14,"expiration_date":"2024-05-31","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-23-005234","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123005234/doc4.xml","form_type":"4"}},{"id":354486,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-27T21:18:18.000Z","date":"2023-01-25","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Fully vested."}],"balance_after":5429,"derivative":{"exercise_price":72.14,"expiration_date":"2024-05-31","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-23-005234","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123005234/doc4.xml","form_type":"4"}},{"id":354485,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-27T21:18:18.000Z","date":"2023-01-26","kind":"sale","acquired":false,"shares":680,"price":320.94,"value":218239.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Open market sales reported on this line occurred at a weighted average price of $320.94 (range $320.89 to $320.99)."}],"balance_after":1875,"source":{"system":"sec-edgar","filing":"0001209191-23-005234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123005234/doc4.xml","form_type":"4"}},{"id":354484,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-27T21:18:18.000Z","date":"2023-01-26","kind":"sale","acquired":false,"shares":400,"price":320.25,"value":128100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Open market sales reported on this line occurred at a weighted average price of $320.25 (range $319.80 to $320.77)."}],"balance_after":2555,"source":{"system":"sec-edgar","filing":"0001209191-23-005234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123005234/doc4.xml","form_type":"4"}},{"id":354483,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-27T21:18:18.000Z","date":"2023-01-26","kind":"sale","acquired":false,"shares":478,"price":319.25,"value":152601.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Open market sales reported on this line occurred at a weighted average price of $319.25 (range $318.79 to $319.56)."}],"balance_after":2955,"source":{"system":"sec-edgar","filing":"0001209191-23-005234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123005234/doc4.xml","form_type":"4"}},{"id":354482,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-27T21:18:18.000Z","date":"2023-01-26","kind":"sale","acquired":false,"shares":1000,"price":317.95,"value":317950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Open market sales reported on this line occurred at a weighted average price of $317.95 (range $317.43 to $318.35)."}],"balance_after":3433,"source":{"system":"sec-edgar","filing":"0001209191-23-005234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123005234/doc4.xml","form_type":"4"}},{"id":354481,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-27T21:18:18.000Z","date":"2023-01-26","kind":"sale","acquired":false,"shares":1140,"price":316.82,"value":361174.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $316.82 (range $316.23 to $317.16)."}],"balance_after":4433,"source":{"system":"sec-edgar","filing":"0001209191-23-005234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123005234/doc4.xml","form_type":"4"}},{"id":354480,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-27T21:18:18.000Z","date":"2023-01-26","kind":"sale","acquired":false,"shares":302,"price":315.42,"value":95256.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $315.42 (range $315.23 to $315.66)."}],"balance_after":5573,"source":{"system":"sec-edgar","filing":"0001209191-23-005234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123005234/doc4.xml","form_type":"4"}},{"id":354479,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-27T21:18:18.000Z","date":"2023-01-26","kind":"exercise","acquired":true,"shares":4000,"price":72.14,"value":288560.0,"ownership":{"direct":true},"balance_after":5875,"source":{"system":"sec-edgar","filing":"0001209191-23-005234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123005234/doc4.xml","form_type":"4"}},{"id":354478,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-27T21:18:18.000Z","date":"2023-01-25","kind":"sale","acquired":false,"shares":579,"price":314.95,"value":182356.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $314.95 (range $314.58 to $315.14)."}],"balance_after":1875,"source":{"system":"sec-edgar","filing":"0001209191-23-005234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123005234/doc4.xml","form_type":"4"}},{"id":354477,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-27T21:18:18.000Z","date":"2023-01-25","kind":"sale","acquired":false,"shares":2621,"price":314.1,"value":823256.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $314.10 (range $313.53 to $314.50)."}],"balance_after":2454,"source":{"system":"sec-edgar","filing":"0001209191-23-005234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123005234/doc4.xml","form_type":"4"}},{"id":354476,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-27T21:18:18.000Z","date":"2023-01-25","kind":"sale","acquired":false,"shares":800,"price":312.8,"value":250240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $312.80 (range $312.41 to $313.06)."}],"balance_after":5075,"source":{"system":"sec-edgar","filing":"0001209191-23-005234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123005234/doc4.xml","form_type":"4"}},{"id":354475,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-27T21:18:18.000Z","date":"2023-01-25","kind":"exercise","acquired":true,"shares":4000,"price":72.14,"value":288560.0,"ownership":{"direct":true},"balance_after":5875,"source":{"system":"sec-edgar","filing":"0001209191-23-005234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123005234/doc4.xml","form_type":"4"}},{"id":354553,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-25T21:08:09.000Z","date":"2023-01-24","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested."}],"balance_after":9429,"derivative":{"exercise_price":72.14,"expiration_date":"2024-05-31","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-23-004816","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123004816/doc4.xml","form_type":"4"}},{"id":354552,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-25T21:08:09.000Z","date":"2023-01-23","kind":"exercise","acquired":false,"shares":2129,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested."}],"balance_after":13429,"derivative":{"exercise_price":72.14,"expiration_date":"2024-05-31","underlying":"Common Stock","underlying_shares":2129},"source":{"system":"sec-edgar","filing":"0001209191-23-004816","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123004816/doc4.xml","form_type":"4"}},{"id":354551,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-25T21:08:09.000Z","date":"2023-01-24","kind":"sale","acquired":false,"shares":1489,"price":313.36,"value":466593.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $313.36 (range $313.00 to $313.73)."}],"balance_after":1875,"source":{"system":"sec-edgar","filing":"0001209191-23-004816","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123004816/doc4.xml","form_type":"4"}},{"id":354550,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-25T21:08:09.000Z","date":"2023-01-24","kind":"sale","acquired":false,"shares":2511,"price":312.29,"value":784160.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $312.29 (range $312.00 to $312.92)."}],"balance_after":3364,"source":{"system":"sec-edgar","filing":"0001209191-23-004816","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123004816/doc4.xml","form_type":"4"}},{"id":354549,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-25T21:08:09.000Z","date":"2023-01-24","kind":"exercise","acquired":true,"shares":4000,"price":72.14,"value":288560.0,"ownership":{"direct":true},"balance_after":5875,"source":{"system":"sec-edgar","filing":"0001209191-23-004816","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123004816/doc4.xml","form_type":"4"}},{"id":354548,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-25T21:08:09.000Z","date":"2023-01-23","kind":"sale","acquired":false,"shares":2129,"price":312.02,"value":664290.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $312.02 (range $312.00 to $312.17)."}],"balance_after":1875,"source":{"system":"sec-edgar","filing":"0001209191-23-004816","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123004816/doc4.xml","form_type":"4"}},{"id":354547,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-25T21:08:09.000Z","date":"2023-01-23","kind":"exercise","acquired":true,"shares":2129,"price":72.14,"value":153586.06,"ownership":{"direct":true},"balance_after":4004,"source":{"system":"sec-edgar","filing":"0001209191-23-004816","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123004816/doc4.xml","form_type":"4"}},{"id":354682,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-19T21:07:54.000Z","date":"2023-01-18","kind":"exercise","acquired":false,"shares":442,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."}],"balance_after":15558,"derivative":{"exercise_price":72.14,"expiration_date":"2024-05-31","underlying":"Common Stock","underlying_shares":442},"source":{"system":"sec-edgar","filing":"0001209191-23-004005","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123004005/doc4.xml","form_type":"4"}},{"id":354681,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-19T21:07:54.000Z","date":"2023-01-17","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."}],"balance_after":16000,"derivative":{"exercise_price":72.14,"expiration_date":"2024-05-31","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-23-004005","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123004005/doc4.xml","form_type":"4"}},{"id":354680,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-19T21:07:54.000Z","date":"2023-01-18","kind":"sale","acquired":false,"shares":442,"price":312.17,"value":137979.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $312.17 (range $312.00 to $312.53)."}],"balance_after":1875,"source":{"system":"sec-edgar","filing":"0001209191-23-004005","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123004005/doc4.xml","form_type":"4"}},{"id":354679,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-19T21:07:54.000Z","date":"2023-01-18","kind":"exercise","acquired":true,"shares":442,"price":72.14,"value":31885.88,"ownership":{"direct":true},"balance_after":2317,"source":{"system":"sec-edgar","filing":"0001209191-23-004005","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123004005/doc4.xml","form_type":"4"}},{"id":354678,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-19T21:07:54.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":4000,"price":312.03,"value":1248120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $312.03 (range $312.00 to $312.14)."}],"balance_after":1875,"source":{"system":"sec-edgar","filing":"0001209191-23-004005","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123004005/doc4.xml","form_type":"4"}},{"id":354677,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-19T21:07:54.000Z","date":"2023-01-17","kind":"exercise","acquired":true,"shares":4000,"price":72.14,"value":288560.0,"ownership":{"direct":true},"balance_after":5875,"source":{"system":"sec-edgar","filing":"0001209191-23-004005","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123004005/doc4.xml","form_type":"4"}},{"id":361986,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-03T20:53:52.000Z","date":"2022-05-01","kind":"grant","acquired":true,"shares":4462,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4462,"derivative":{"exercise_price":276.17,"exercise_date":"2022-05-01","expiration_date":"2032-04-30","underlying":"Common Stock","underlying_shares":4462},"source":{"system":"sec-edgar","filing":"0000899243-22-016342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016342/doc4.xml","form_type":"4"}},{"id":362426,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-20T20:05:31.000Z","date":"2022-04-18","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":81.54,"expiration_date":"2023-05-31","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000899243-22-015163","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322015163/doc4.xml","form_type":"4"}},{"id":362425,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-20T20:05:31.000Z","date":"2022-04-18","kind":"sale","acquired":false,"shares":119,"price":286.8,"value":34129.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $286.80 (range $286.68 to $286.82)."}],"balance_after":1875,"source":{"system":"sec-edgar","filing":"0000899243-22-015163","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322015163/doc4.xml","form_type":"4"}},{"id":362424,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-20T20:05:31.000Z","date":"2022-04-18","kind":"sale","acquired":false,"shares":491,"price":285.16,"value":140013.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $285.16 (range $284.88 to $285.63)."}],"balance_after":1994,"source":{"system":"sec-edgar","filing":"0000899243-22-015163","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322015163/doc4.xml","form_type":"4"}},{"id":362423,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-20T20:05:31.000Z","date":"2022-04-18","kind":"sale","acquired":false,"shares":1008,"price":284.06,"value":286332.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $284.06 (range $283.72 to $284.46)."}],"balance_after":2485,"source":{"system":"sec-edgar","filing":"0000899243-22-015163","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322015163/doc4.xml","form_type":"4"}},{"id":362422,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-20T20:05:31.000Z","date":"2022-04-18","kind":"sale","acquired":false,"shares":382,"price":282.7,"value":107991.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $282.70 (range $282.40 to $283.15)."}],"balance_after":3493,"source":{"system":"sec-edgar","filing":"0000899243-22-015163","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322015163/doc4.xml","form_type":"4"}},{"id":362421,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-20T20:05:31.000Z","date":"2022-04-18","kind":"exercise","acquired":true,"shares":2000,"price":81.54,"value":163080.0,"ownership":{"direct":true},"balance_after":3875,"source":{"system":"sec-edgar","filing":"0000899243-22-015163","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322015163/doc4.xml","form_type":"4"}},{"id":362646,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-18T20:05:19.000Z","date":"2022-04-14","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Fully vested."}],"balance_after":2000,"derivative":{"exercise_price":81.54,"expiration_date":"2023-05-31","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000899243-22-014962","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014962/doc4.xml","form_type":"4"}},{"id":362645,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-18T20:05:19.000Z","date":"2022-04-14","kind":"sale","acquired":false,"shares":400,"price":291.18,"value":116472.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $291.18 (range $290.80 to $291.64)."}],"balance_after":1875,"source":{"system":"sec-edgar","filing":"0000899243-22-014962","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014962/doc4.xml","form_type":"4"}},{"id":362644,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-18T20:05:19.000Z","date":"2022-04-14","kind":"sale","acquired":false,"shares":400,"price":289.84,"value":115936.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $289.84 (range $289.69 to $289.96)."}],"balance_after":2275,"source":{"system":"sec-edgar","filing":"0000899243-22-014962","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014962/doc4.xml","form_type":"4"}},{"id":362643,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-18T20:05:19.000Z","date":"2022-04-14","kind":"sale","acquired":false,"shares":252,"price":288.92,"value":72807.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $288.92 (range $288.51 to $289.24)."}],"balance_after":2675,"source":{"system":"sec-edgar","filing":"0000899243-22-014962","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014962/doc4.xml","form_type":"4"}},{"id":362642,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-18T20:05:19.000Z","date":"2022-04-14","kind":"sale","acquired":false,"shares":948,"price":287.87,"value":272900.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $287.87 (range $287.49 to $288.26)."}],"balance_after":2927,"source":{"system":"sec-edgar","filing":"0000899243-22-014962","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014962/doc4.xml","form_type":"4"}},{"id":362641,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-18T20:05:19.000Z","date":"2022-04-14","kind":"exercise","acquired":true,"shares":2000,"price":81.54,"value":163080.0,"ownership":{"direct":true},"balance_after":3875,"source":{"system":"sec-edgar","filing":"0000899243-22-014962","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014962/doc4.xml","form_type":"4"}},{"id":362702,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-14T20:35:05.000Z","date":"2022-04-13","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"Fully vested."}],"balance_after":4000,"derivative":{"exercise_price":81.54,"expiration_date":"2023-05-31","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000899243-22-014804","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014804/doc4.xml","form_type":"4"}},{"id":362701,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-14T20:35:05.000Z","date":"2022-04-12","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"Fully vested."}],"balance_after":6000,"derivative":{"exercise_price":81.54,"expiration_date":"2023-05-31","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000899243-22-014804","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014804/doc4.xml","form_type":"4"}},{"id":362700,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-14T20:35:05.000Z","date":"2022-04-13","kind":"sale","acquired":false,"shares":354,"price":291.12,"value":103056.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Open market sales reported on this line occurred at a weighted average price of $291.12 (range $290.80 to $291.42)."}],"balance_after":1875,"source":{"system":"sec-edgar","filing":"0000899243-22-014804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014804/doc4.xml","form_type":"4"}},{"id":362699,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-14T20:35:05.000Z","date":"2022-04-13","kind":"sale","acquired":false,"shares":200,"price":290.17,"value":58034.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Open market sales reported on this line occurred at a weighted average price of $290.17 (range $289.72 to $290.62)."}],"balance_after":2229,"source":{"system":"sec-edgar","filing":"0000899243-22-014804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014804/doc4.xml","form_type":"4"}},{"id":362698,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-14T20:35:05.000Z","date":"2022-04-13","kind":"sale","acquired":false,"shares":400,"price":288.55,"value":115420.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Open market sales reported on this line occurred at a weighted average price of $288.55 (range $288.23 to $289.11)."}],"balance_after":2429,"source":{"system":"sec-edgar","filing":"0000899243-22-014804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014804/doc4.xml","form_type":"4"}},{"id":362697,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-14T20:35:05.000Z","date":"2022-04-13","kind":"sale","acquired":false,"shares":200,"price":287.42,"value":57484.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Open market sales reported on this line occurred at a weighted average price of $287.42 (range $287.02 to $287.83)."}],"balance_after":2829,"source":{"system":"sec-edgar","filing":"0000899243-22-014804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014804/doc4.xml","form_type":"4"}},{"id":362696,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-14T20:35:05.000Z","date":"2022-04-13","kind":"sale","acquired":false,"shares":300,"price":286.24,"value":85872.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Open market sales reported on this line occurred at a weighted average price of $286.24 (range $285.99 to $286.60)."}],"balance_after":3029,"source":{"system":"sec-edgar","filing":"0000899243-22-014804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014804/doc4.xml","form_type":"4"}},{"id":362695,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-14T20:35:05.000Z","date":"2022-04-13","kind":"sale","acquired":false,"shares":228,"price":284.9,"value":64957.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Open market sales reported on this line occurred at a weighted average price of $284.90 (range $284.66 to $284.95)."}],"balance_after":3329,"source":{"system":"sec-edgar","filing":"0000899243-22-014804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014804/doc4.xml","form_type":"4"}},{"id":362694,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-14T20:35:05.000Z","date":"2022-04-13","kind":"sale","acquired":false,"shares":300,"price":283.73,"value":85119.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $283.73 (range $283.30 to $284.10)."}],"balance_after":3557,"source":{"system":"sec-edgar","filing":"0000899243-22-014804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014804/doc4.xml","form_type":"4"}},{"id":362693,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-14T20:35:05.000Z","date":"2022-04-13","kind":"sale","acquired":false,"shares":18,"price":281.49,"value":5066.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."}],"balance_after":3857,"source":{"system":"sec-edgar","filing":"0000899243-22-014804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014804/doc4.xml","form_type":"4"}},{"id":362692,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-14T20:35:05.000Z","date":"2022-04-13","kind":"exercise","acquired":true,"shares":2000,"price":81.54,"value":163080.0,"ownership":{"direct":true},"balance_after":3875,"source":{"system":"sec-edgar","filing":"0000899243-22-014804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014804/doc4.xml","form_type":"4"}},{"id":362691,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-14T20:35:05.000Z","date":"2022-04-12","kind":"sale","acquired":false,"shares":300,"price":283.15,"value":84945.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $283.15 (range $282.73 to $283.57)."}],"balance_after":1875,"source":{"system":"sec-edgar","filing":"0000899243-22-014804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014804/doc4.xml","form_type":"4"}},{"id":362690,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-14T20:35:05.000Z","date":"2022-04-12","kind":"sale","acquired":false,"shares":318,"price":281.7,"value":89580.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $281.70 (range $281.45 to $281.98)."}],"balance_after":2175,"source":{"system":"sec-edgar","filing":"0000899243-22-014804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014804/doc4.xml","form_type":"4"}},{"id":362689,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-14T20:35:05.000Z","date":"2022-04-12","kind":"sale","acquired":false,"shares":1182,"price":280.61,"value":331681.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $280.61 (range $280.24 to $281.19)."}],"balance_after":2493,"source":{"system":"sec-edgar","filing":"0000899243-22-014804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014804/doc4.xml","form_type":"4"}},{"id":362688,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-14T20:35:05.000Z","date":"2022-04-12","kind":"sale","acquired":false,"shares":200,"price":279.22,"value":55844.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $279.22 (range $279.14 to $279.30)."}],"balance_after":3675,"source":{"system":"sec-edgar","filing":"0000899243-22-014804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014804/doc4.xml","form_type":"4"}},{"id":362687,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-14T20:35:05.000Z","date":"2022-04-12","kind":"exercise","acquired":true,"shares":2000,"price":81.54,"value":163080.0,"ownership":{"direct":true},"balance_after":3875,"source":{"system":"sec-edgar","filing":"0000899243-22-014804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014804/doc4.xml","form_type":"4"}},{"id":362768,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-12T20:07:18.000Z","date":"2022-04-11","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Fully vested."}],"balance_after":8000,"derivative":{"exercise_price":81.54,"expiration_date":"2023-05-31","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000899243-22-014551","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014551/doc4.xml","form_type":"4"}},{"id":362767,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-12T20:07:18.000Z","date":"2022-04-08","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Fully vested."}],"balance_after":10000,"derivative":{"exercise_price":81.54,"expiration_date":"2023-05-31","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000899243-22-014551","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014551/doc4.xml","form_type":"4"}},{"id":362766,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-12T20:07:18.000Z","date":"2022-04-11","kind":"sale","acquired":false,"shares":110,"price":281.58,"value":30973.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Open market sales reported on this line occurred at a weighted average price of $281.58 (range $281.55 to $281.58)."}],"balance_after":1875,"source":{"system":"sec-edgar","filing":"0000899243-22-014551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014551/doc4.xml","form_type":"4"}},{"id":362765,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-12T20:07:18.000Z","date":"2022-04-11","kind":"sale","acquired":false,"shares":968,"price":280.62,"value":271640.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Open market sales reported on this line occurred at a weighted average price of $280.62 (range $280.31 to $281.28)."}],"balance_after":1985,"source":{"system":"sec-edgar","filing":"0000899243-22-014551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014551/doc4.xml","form_type":"4"}},{"id":362764,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-12T20:07:18.000Z","date":"2022-04-11","kind":"sale","acquired":false,"shares":922,"price":279.81,"value":257984.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $279.81 (range $279.29 to $280.18)."}],"balance_after":2953,"source":{"system":"sec-edgar","filing":"0000899243-22-014551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014551/doc4.xml","form_type":"4"}},{"id":362763,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-12T20:07:18.000Z","date":"2022-04-11","kind":"exercise","acquired":true,"shares":2000,"price":81.54,"value":163080.0,"ownership":{"direct":true},"balance_after":3875,"source":{"system":"sec-edgar","filing":"0000899243-22-014551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014551/doc4.xml","form_type":"4"}},{"id":362762,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-12T20:07:18.000Z","date":"2022-04-08","kind":"sale","acquired":false,"shares":452,"price":280.37,"value":126727.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $280.37 (range $280.06 to $281.02)."}],"balance_after":1875,"source":{"system":"sec-edgar","filing":"0000899243-22-014551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014551/doc4.xml","form_type":"4"}},{"id":362761,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-12T20:07:18.000Z","date":"2022-04-08","kind":"sale","acquired":false,"shares":700,"price":279.36,"value":195552.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $279.36 (range $278.86 to $279.74)."}],"balance_after":2327,"source":{"system":"sec-edgar","filing":"0000899243-22-014551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014551/doc4.xml","form_type":"4"}},{"id":362760,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-12T20:07:18.000Z","date":"2022-04-08","kind":"sale","acquired":false,"shares":430,"price":277.29,"value":119234.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $277.29 (range $277.16 to $277.46)."}],"balance_after":3027,"source":{"system":"sec-edgar","filing":"0000899243-22-014551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014551/doc4.xml","form_type":"4"}},{"id":362759,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-12T20:07:18.000Z","date":"2022-04-08","kind":"sale","acquired":false,"shares":418,"price":276.62,"value":115627.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $276.62 (range $276.08 to $276.81)."}],"balance_after":3457,"source":{"system":"sec-edgar","filing":"0000899243-22-014551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014551/doc4.xml","form_type":"4"}},{"id":362758,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-12T20:07:18.000Z","date":"2022-04-08","kind":"exercise","acquired":true,"shares":2000,"price":81.54,"value":163080.0,"ownership":{"direct":true},"balance_after":3875,"source":{"system":"sec-edgar","filing":"0000899243-22-014551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014551/doc4.xml","form_type":"4"}},{"id":362831,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-08T21:57:26.000Z","date":"2022-04-07","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested."}],"balance_after":12000,"derivative":{"exercise_price":81.54,"expiration_date":"2023-05-31","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000899243-22-014367","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014367/doc4.xml","form_type":"4"}},{"id":362830,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-08T21:57:26.000Z","date":"2022-04-06","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested."}],"balance_after":14000,"derivative":{"exercise_price":81.54,"expiration_date":"2023-05-31","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000899243-22-014367","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014367/doc4.xml","form_type":"4"}},{"id":362829,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-08T21:57:26.000Z","date":"2022-04-07","kind":"sale","acquired":false,"shares":100,"price":277.02,"value":27702.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."}],"balance_after":1875,"source":{"system":"sec-edgar","filing":"0000899243-22-014367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014367/doc4.xml","form_type":"4"}},{"id":362828,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-08T21:57:26.000Z","date":"2022-04-07","kind":"sale","acquired":false,"shares":727,"price":276.37,"value":200920.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Open market sales reported on this line occurred at a weighted average price of $276.37 (range $275.94 to $276.82)."}],"balance_after":1975,"source":{"system":"sec-edgar","filing":"0000899243-22-014367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014367/doc4.xml","form_type":"4"}},{"id":362827,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-08T21:57:26.000Z","date":"2022-04-07","kind":"sale","acquired":false,"shares":256,"price":275.26,"value":70466.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Open market sales reported on this line occurred at a weighted average price of $275.26 (range $274.64 to $275.43)."}],"balance_after":2702,"source":{"system":"sec-edgar","filing":"0000899243-22-014367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014367/doc4.xml","form_type":"4"}},{"id":362826,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-08T21:57:26.000Z","date":"2022-04-07","kind":"sale","acquired":false,"shares":500,"price":273.78,"value":136890.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Open market sales reported on this line occurred at a weighted average price of $273.78 (range $273.52 to $273.98)."}],"balance_after":2958,"source":{"system":"sec-edgar","filing":"0000899243-22-014367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014367/doc4.xml","form_type":"4"}},{"id":362825,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-08T21:57:26.000Z","date":"2022-04-07","kind":"sale","acquired":false,"shares":417,"price":272.76,"value":113740.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $272.76 (range $272.50 to $273.28)."}],"balance_after":3458,"source":{"system":"sec-edgar","filing":"0000899243-22-014367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014367/doc4.xml","form_type":"4"}},{"id":362824,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-08T21:57:26.000Z","date":"2022-04-07","kind":"exercise","acquired":true,"shares":2000,"price":81.54,"value":163080.0,"ownership":{"direct":true},"balance_after":3875,"source":{"system":"sec-edgar","filing":"0000899243-22-014367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014367/doc4.xml","form_type":"4"}},{"id":362823,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-08T21:57:26.000Z","date":"2022-04-06","kind":"sale","acquired":false,"shares":83,"price":272.84,"value":22645.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $272.84 (range $272.56 to $272.97)."}],"balance_after":1875,"source":{"system":"sec-edgar","filing":"0000899243-22-014367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014367/doc4.xml","form_type":"4"}},{"id":362822,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-08T21:57:26.000Z","date":"2022-04-06","kind":"sale","acquired":false,"shares":1600,"price":271.78,"value":434848.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $271.78 (range $271.43 to $272.33)."}],"balance_after":1958,"source":{"system":"sec-edgar","filing":"0000899243-22-014367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014367/doc4.xml","form_type":"4"}},{"id":362821,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-08T21:57:26.000Z","date":"2022-04-06","kind":"sale","acquired":false,"shares":300,"price":270.67,"value":81201.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $270.67 (range $270.42 to $270.88)."}],"balance_after":3558,"source":{"system":"sec-edgar","filing":"0000899243-22-014367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014367/doc4.xml","form_type":"4"}},{"id":362820,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-08T21:57:26.000Z","date":"2022-04-06","kind":"sale","acquired":false,"shares":17,"price":267.57,"value":4548.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."}],"balance_after":3858,"source":{"system":"sec-edgar","filing":"0000899243-22-014367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014367/doc4.xml","form_type":"4"}},{"id":362819,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-08T21:57:26.000Z","date":"2022-04-06","kind":"exercise","acquired":true,"shares":2000,"price":81.54,"value":163080.0,"ownership":{"direct":true},"balance_after":3875,"source":{"system":"sec-edgar","filing":"0000899243-22-014367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014367/doc4.xml","form_type":"4"}},{"id":362923,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-06T20:59:58.000Z","date":"2022-04-05","kind":"exercise","acquired":false,"shares":2000,"price":81.54,"value":163080.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Fully vested."}],"balance_after":16000,"derivative":{"exercise_price":81.54,"expiration_date":"2023-05-31","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000899243-22-014117","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014117/doc4.xml","form_type":"4"}},{"id":362922,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-06T20:59:58.000Z","date":"2022-04-04","kind":"exercise","acquired":false,"shares":2000,"price":81.54,"value":163080.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Fully vested."}],"balance_after":18000,"derivative":{"exercise_price":81.54,"expiration_date":"2023-05-31","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000899243-22-014117","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014117/doc4.xml","form_type":"4"}},{"id":362921,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T20:59:58.000Z","date":"2022-04-05","kind":"sale","acquired":false,"shares":461,"price":274.66,"value":126618.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Open market sales reported on this line occurred at a weighted average price of $274.66 (range $274.63 to $274.68)."}],"balance_after":1875,"source":{"system":"sec-edgar","filing":"0000899243-22-014117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014117/doc4.xml","form_type":"4"}},{"id":362920,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T20:59:58.000Z","date":"2022-04-05","kind":"sale","acquired":false,"shares":100,"price":273.5,"value":27350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."}],"balance_after":2336,"source":{"system":"sec-edgar","filing":"0000899243-22-014117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014117/doc4.xml","form_type":"4"}},{"id":362919,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T20:59:58.000Z","date":"2022-04-05","kind":"sale","acquired":false,"shares":600,"price":272.6,"value":163560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $272.60 (range $272.36 to $273.34)."}],"balance_after":2436,"source":{"system":"sec-edgar","filing":"0000899243-22-014117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014117/doc4.xml","form_type":"4"}},{"id":362918,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T20:59:58.000Z","date":"2022-04-05","kind":"sale","acquired":false,"shares":488,"price":271.94,"value":132706.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $271.94 (range $271.35 to $272.27)."}],"balance_after":3036,"source":{"system":"sec-edgar","filing":"0000899243-22-014117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014117/doc4.xml","form_type":"4"}},{"id":362917,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T20:59:58.000Z","date":"2022-04-05","kind":"sale","acquired":false,"shares":334,"price":270.05,"value":90196.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $270.05 (range $269.79 to $270.64)."}],"balance_after":3524,"source":{"system":"sec-edgar","filing":"0000899243-22-014117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014117/doc4.xml","form_type":"4"}},{"id":362916,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T20:59:58.000Z","date":"2022-04-05","kind":"sale","acquired":false,"shares":17,"price":268.3,"value":4561.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."}],"balance_after":3858,"source":{"system":"sec-edgar","filing":"0000899243-22-014117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014117/doc4.xml","form_type":"4"}},{"id":362915,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T20:59:58.000Z","date":"2022-04-05","kind":"exercise","acquired":true,"shares":2000,"price":81.54,"value":163080.0,"ownership":{"direct":true},"balance_after":3875,"source":{"system":"sec-edgar","filing":"0000899243-22-014117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014117/doc4.xml","form_type":"4"}},{"id":362914,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T20:59:58.000Z","date":"2022-04-04","kind":"sale","acquired":false,"shares":983,"price":268.36,"value":263797.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $268.36 (range $267.97 to $268.81)."}],"balance_after":1875,"source":{"system":"sec-edgar","filing":"0000899243-22-014117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014117/doc4.xml","form_type":"4"}},{"id":362913,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T20:59:58.000Z","date":"2022-04-04","kind":"sale","acquired":false,"shares":917,"price":267.23,"value":245049.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $267.23 (range $266.85 to $267.79)."}],"balance_after":2858,"source":{"system":"sec-edgar","filing":"0000899243-22-014117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014117/doc4.xml","form_type":"4"}},{"id":362912,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T20:59:58.000Z","date":"2022-04-04","kind":"sale","acquired":false,"shares":100,"price":265.83,"value":26583.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1."}],"balance_after":3775,"source":{"system":"sec-edgar","filing":"0000899243-22-014117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014117/doc4.xml","form_type":"4"}},{"id":362911,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T20:59:58.000Z","date":"2022-04-04","kind":"exercise","acquired":true,"shares":2000,"price":81.54,"value":163080.0,"ownership":{"direct":true},"balance_after":3875,"source":{"system":"sec-edgar","filing":"0000899243-22-014117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014117/doc4.xml","form_type":"4"}},{"id":376077,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-04T20:13:51.000Z","date":"2021-05-01","kind":"grant","acquired":true,"shares":6067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":6067,"derivative":{"exercise_price":217.2,"expiration_date":"2031-04-30","underlying":"Common Stock","underlying_shares":6067},"source":{"system":"sec-edgar","filing":"0001209191-21-029852","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121029852/doc4.xml","form_type":"4"}},{"id":389773,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15359,"kind":"person","name":"Lee Yuchun","position":1,"cik":"0001334365","reported_name":"Lee Yuchun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-03T20:31:51.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":4527,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":4527,"derivative":{"exercise_price":286.27,"expiration_date":"2030-05-31","underlying":"Common Stock","underlying_shares":4527},"source":{"system":"sec-edgar","filing":"0001209191-20-034038","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120034038/doc4.xml","form_type":"4"}}],"next_cursor":"2020-06-03T20:31:51.000000Z,389773"}